Antimicrobial Technology Firm Nobio Finalizes Investment by aMoon Fund and Dr. Ole Jensen
Nobio Ltd., developer of embedded, long-acting antimicrobial particle technology, today announced the closing of a $3.6 million investment by aMoon Fund and Dr. Ole Jensen. … more